A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
53
Participants
Timeline
Start Date
June 30, 2016
Primary Completion Date
March 1, 2017
Study Completion Date
March 1, 2017
Conditions
Atopic Dermatitis
Interventions
DRUG
ZPL-5212372 1% w/w Ointment BID
DRUG
Placebo Ointment BID
Trial Locations (3)
Unknown
MAC, Blackpool
MAC, Leeds
MAC, Manchester
All Listed Sponsors
lead
Ziarco Pharma Ltd
INDUSTRY
NCT02795832 - A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter